Concepedia

Per Olaf Huusfeldt

PO

Statistics

Publications

9

Citations

946

H-Index

9

Active since

1999

Affiliations

Novo Nordisk (Denmark)(Current)

Per Olaf Huusfeldt is an author at Novo Nordisk (Denmark) specializing in medicinal chemistry, pharmacology, and structure-activity relationships.

Publications per year

1999–2003

9

Publications

9

Potent Derivatives of Glucagon-like Peptide-1 with Pharmacokinetic Properties Suitable for Once Daily Administration

Lotte Bjerre Knudsen, Per F. Nielsen, Per Olaf Huusfeldt et al. · Journal of Medicinal Chemistry · 2000 · 687 citations · Full text

, , +14

Synthesis of Novel γ-Aminobutyric Acid (GABA) Uptake Inhibitors. 5. Preparation and Structure−Activity Studies of Tricyclic Analogues of Known GABA Uptake Inhibitors

Knud Erik Andersen, Jan L. Sørensen, Jesper Lau et al. · Journal of Medicinal Chemistry · 2001 · 53 citations · Full text

, , +15

Synthesis of Novel GABA Uptake Inhibitors. 4. Bioisosteric Transformation and Successive Optimization of Known GABA Uptake Inhibitors Leading to a Series of Potent Anticonvulsant Drug Candidates

Knud Erik Andersen, Jan L. Sørensen, Per Olaf Huusfeldt et al. · Journal of Medicinal Chemistry · 1999 · 44 citations · Full text

, , +16

Synthesis of novel GABA uptake inhibitors. part 6 : Preparation and evaluation of N-Ω asymmetrically substituted nipecotic acid derivatives

Knud Erik Andersen, Jesper Lau, Behrend F. Lundt et al. · Bioorganic & Medicinal Chemistry · 2001 · 40 citations

, , +15

GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes: Selection of NN2211 for clinical development

Lisbeth B. Knudsen, Christina Bjenning, S Bregenholt et al. · Drugs of the Future · 2001 · 35 citations

, , +16

1–5 of 9